Case Report
PDF EndNote BibTex Cite

Could COVID-19 infection determine diabetic foot mortality?

Year 2021, Volume 60, Issue 2, 169 - 171, 30.06.2021
https://doi.org/10.19161/etd.950926

Abstract

COVID-19 infection is increasing in severity today and may appear with various clinical presentations. Apart from the common respiratory symptoms of COVID-19, patients can also be diagnosed with different symptoms. The presence of diabetes aggravates the course of COVID-19 infection. Difficulties in accessing healthcare services during the pandemic process of individuals with chronic diseases, and the complication of diabetes, which is a chronic disease with high morbidity and mortality, have led to rapid progression in diabetic foot ulcers and increases in amputation rates. COVID-19 infection is also thought to contribute to this progression. With this case, we wanted to evaluate the relationship between the rapid progression of the ulcer of our patient with diabetic foot ulcer and COVID-19 infection.

References

  • Zhu N, Zhang D, Wang W. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020 Feb 20; 382 (8): 727-733.
  • Amraei R, Rahimi N. COVID-19, renin-angiotensin system and endothelial dysfunction. Cells. 2020 Jul 9; 9 (7): 1652.
  • Iba T, Levy JH, Levi M, Thachil J. Coagulopathy in COVID-19. J Thromb Haemost. 2020 Sep;18 (9): 2103-2109.
  • Huang C, Wang Y, Li X. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020 Feb 15; 395 (10223): 497-506.
  • Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020 Mar 17; 323 (11): 1061-1069.
  • Freeman E.E, McMahon D.E, Lipoff J.B. The spectrum of COVID-19-associated dermatologic manifestations: an international registry of 716 patients from 31 countries. J Am Acad Dermatol. 2020 Oct; 83 (4): 1118-1129.
  • Baeck M, Herman A. COVID toes: Where do we stand with the current evidence? Int. J. Infect. Dis. 2021 Jan; 102: 53-55

COVID-19 enfeksiyonu, diyabetik ayakta mortaliteyi belirliyor olabilir mi?

Year 2021, Volume 60, Issue 2, 169 - 171, 30.06.2021
https://doi.org/10.19161/etd.950926

Abstract

COVID-19 enfeksiyonu günümüzde giderek şiddetini arttırmakta ve çeşitli klinik prezentasyonlarla karşımıza çıkabilmektedir. COVID-19’un yaygın görülen solunum yolları semptomları dışında hastalar farklı semptomlarla da tanı alabilmektedirler. Diyabet varlığı, COVID-19 enfeksiyon seyrini ağırlaştırmaktadır. Kronik hastalığı olan bireylerin pandemi sürecinde sağlık hizmetlerine ulaşım zorlukları, kronik bir hastalık olan diyabetin, morbidite ve mortalitesi yüksek olan komplikasyonu diyabetik ayak ülserinde hızlı progresyonlara ve ampütasyon oranlarında artışlara neden olmuştur. COVID-19 enfeksiyonun da bu progresyona katkıda bulunduğu düşünülmektedir. Bu olgumuzla diyabetik ayak ülseri olan hastamızın, ülserindeki hızlı progresyonun COVID-19 enfeksiyonu ile olan ilişkisini değerlendirmek istedik.

References

  • Zhu N, Zhang D, Wang W. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020 Feb 20; 382 (8): 727-733.
  • Amraei R, Rahimi N. COVID-19, renin-angiotensin system and endothelial dysfunction. Cells. 2020 Jul 9; 9 (7): 1652.
  • Iba T, Levy JH, Levi M, Thachil J. Coagulopathy in COVID-19. J Thromb Haemost. 2020 Sep;18 (9): 2103-2109.
  • Huang C, Wang Y, Li X. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020 Feb 15; 395 (10223): 497-506.
  • Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020 Mar 17; 323 (11): 1061-1069.
  • Freeman E.E, McMahon D.E, Lipoff J.B. The spectrum of COVID-19-associated dermatologic manifestations: an international registry of 716 patients from 31 countries. J Am Acad Dermatol. 2020 Oct; 83 (4): 1118-1129.
  • Baeck M, Herman A. COVID toes: Where do we stand with the current evidence? Int. J. Infect. Dis. 2021 Jan; 102: 53-55

Details

Primary Language Turkish
Subjects Health Care Sciences and Services
Journal Section Case Reports
Authors

Esma PEHLİVAN KÖROĞLU This is me (Primary Author)
Ege Üniversitesi Tıp Fakültesi Tıp Fakültesi, Endokrinoloji Bilim Dalı, İzmir, Türkiye
0000-0003-3616-8051
Türkiye


Şevki ÇETİNKALP This is me
Ege Üniversitesi Tıp Fakültesi Tıp Fakültesi, Endokrinoloji Bilim Dalı, İzmir, Türkiye
0000-0001-6072-2062
Türkiye

Publication Date June 30, 2021
Application Date April 30, 2021
Acceptance Date May 6, 2021
Published in Issue Year 2021, Volume 60, Issue 2

Cite

Vancouver Pehlivan Köroğlu E. , Çetinkalp Ş. COVID-19 enfeksiyonu, diyabetik ayakta mortaliteyi belirliyor olabilir mi?. Ege Tıp Dergisi. 2021; 60(2): 169-171.